Chlamydia trachomatis IgG seropositivity is associated with lower natural conception rates in ovulatory subfertile women without visible tubal pathology | Zendy

S.F.P.J. Coppus | Zendy; J. A. Land | Zendy; Brent C. Opmeer | Zendy; Pieternel Steures | Zendy; Marinus J.C. Eijkemans | Zendy; Peter G.A. Hompes | Zendy; Patrick M. Bossuyt | Zendy; Fulco van der Veen | Zendy; Ben W. Mol | Zendy; Jan Willem van der Steeg | Zendy

Open Access

Chlamydia trachomatis IgG seropositivity is associated with lower natural conception rates in ovulatory subfertile women without visible tubal pathology

Author(s) -

S.F.P.J. Coppus,

J. A. Land,

Brent C. Opmeer,

Pieternel Steures,

Marinus J.C. Eijkemans,

Peter G.A. Hompes,

Patrick M. Bossuyt,

Fulco van der Veen,

Ben W. Mol,

Jan Willem van der Steeg

Publication year - 2011

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/der307

Subject(s) - hysterosalpingography , chlamydia trachomatis , medicine , gynecology , serology , chlamydiaceae , laparoscopy , chlamydiales , infertility , pelvic inflammatory disease , mycoplasma genitalium , tubal factor infertility , obstetrics , pregnancy , chlamydia , antibody , immunology , biology , surgery , genetics

The relation between Chlamydia trachomatis infection and subsequent tubal damage is widely recognized. As such, C. trachomatis antibody (CAT) testing can be used to triage women for immediate tubal testing with hysterosalpingography (HSG) or laparoscopy. However, once invasive tubal testing has ruled out tubal pathology, CAT serology status is ignored, as its clinical significance is currently unknown. This study aimed to determine whether positive CAT serology is associated with lower spontaneous pregnancy rates in women in whom HSG and/or diagnostic laparoscopy showed no visible tubal pathology.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research